Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Statistically significant associations were observed between sex and the administration of calcium/vitamin D (p = 0.02), hepatoprotective supplements (p = 0.03), and agents categorised as other (p = 0.03).

Source: 3.3. Supplement Use in the Sample. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Network-Based, Cross-Sectional Analysis of Drug-Related Problems Reveals a Strong Association of Possible Inappropriate Medication and Clinical Outcomes in Romanian Elderly Nursing Home Residents

Source: Article title.

Demographic data, clinical history and medication records of 275 patients were collected by the authors from three nursing homes across Mures County, Romania.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Network-Based, Cross-Sectional Analysis of Drug-Related Problems Reveals a Strong Association of Possible Inappropriate Medication and Clinical Outcomes in Romanian Elderly Nursing Home Residents

Cross-sectional study · Medical Sciences · 2026

Original publication title

Network-Based, Cross-Sectional Analysis of Drug-Related Problems Reveals a Strong Association of Possible Inappropriate Medication and Clinical Outcomes in Romanian Elderly Nursing Home Residents

László-István Bába; Hanna Sebesi; Zsolt Gáll; Melinda Kolcsár; Soma Dávid; Noémi Eliza Medvés; George Jîtcă

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Background/Objectives: Polypharmacy is common in elderly nursing home residents (NHR), due to the high prevalence of chronic diseases. This practice increases the risk of clinically significant drug: drug interactions (DDIs) with serious consequences for patient health and safety. The objective of this study was to evaluate the prevalence of DDIs using the UpToDate Drug: Drug Interaction Checker, potentially inappropriate medication (PIM, as defined by the STOPP-START criteria), and their association with major clinical outcomes. Methods: Demographic data, clinical history and detailed medication records of 275 patients from Romania were collected.

Potentially inappropriate medications were identified using 16 selected criteria from the 2023 STOPP/START guidelines. Statistical analysis was performed using GraphPad, R, and Python, involving Chi-squared and Fisher’s exact tests with Benjamini: Hochberg correction, linear regression, and drug-interaction network analysis to characterise interaction frequency and severity. Results: Detailed medical histories over the past year were available for 76 patients. The mean number of drugs prescribed was 9.61 ± 4.47 drugs, with an average of 10.68 ± 10.54 potential interactions per patient. The primary clinical outcome was associated with not respecting certain STOPP-START recommendations (p < 0.01).

Overall, 33.1% of NHRs utilised herbal supplements, resulting in a total of 76 potential herb: drug interactions. Conclusions: The results suggest a potential impact of DDIs on clinical outcomes, underscoring the need for further studies to clarify causality. The use of STOPP/START recommendations and deprescribing could lead to better tolerability and smaller drug-related burden in the institutionalised, elderly population.

Authors’ abstract

Background/Objectives: Polypharmacy is common in elderly nursing home residents (NHR), due to the high prevalence of chronic diseases. This practice increases the risk of clinically significant drug: drug interactions (DDIs) with serious consequences for patient health and safety. The objective of this study was to evaluate the prevalence of DDIs using the UpToDate Drug: Drug Interaction Checker, potentially inappropriate medication (PIM, as defined by the STOPP-START criteria), and their association with major clinical outcomes. Methods: Demographic data, clinical history and detailed medication records of 275 patients from Romania were collected.

Potentially inappropriate medications were identified using 16 selected criteria from the 2023 STOPP/START guidelines. Statistical analysis was performed using GraphPad, R, and Python, involving Chi-squared and Fisher’s exact tests with Benjamini: Hochberg correction, linear regression, and drug-interaction network analysis to characterise interaction frequency and severity. Results: Detailed medical histories over the past year were available for 76 patients. The mean number of drugs prescribed was 9.61 ± 4.47 drugs, with an average of 10.68 ± 10.54 potential interactions per patient. The primary clinical outcome was associated with not respecting certain STOPP-START recommendations (p < 0.01).

Overall, 33.1% of NHRs utilised herbal supplements, resulting in a total of 76 potential herb: drug interactions. Conclusions: The results suggest a potential impact of DDIs on clinical outcomes, underscoring the need for further studies to clarify causality. The use of STOPP/START recommendations and deprescribing could lead to better tolerability and smaller drug-related burden in the institutionalised, elderly population.

Publication and source details

Original title: Network-Based, Cross-Sectional Analysis of Drug-Related Problems Reveals a Strong Association of Possible Inappropriate Medication and Clinical Outcomes in Romanian Elderly Nursing Home Residents

László-István Bába; Hanna Sebesi; Zsolt Gáll; Melinda Kolcsár; Soma Dávid; Noémi Eliza Medvés; George Jîtcă

Medical Sciences · 2026

* Correspondence: zsolt.gall@umfst.ro© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:13:29.759062+00:00

DOI: 10.3390/medsci14030359 · PMC13413638